ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008

In Brief: Moorehead Heads ACCC; Anderson President Elect; Segaloff Dies; RAAD Cleveland Clinic Director

March 22, 1985

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

In Brief: Senate Health Subcommittee Lineup Completed; GAO Calls For More Ionizing Radiation Studies

January 23, 1981